• World-renowned experts Dr. Barb Powers and Dr. Jeff Edwards lead specialty pathology services
• Offering 1:1 consultations and shorter turnaround times than most national labs
• Accessible, accurate and affordable diagnostics with no-contract pricing

Continue reading→

Researchers at University of Arizona Cancer Center used a double-pronged approach to reduce tumor growth in tissue samples of prostate cancer.Continue reading→

A new statewide initiative funded by the Arizona Board of Regents will help Arizona State University, the University of Arizona and Northern Arizona University move their research from the laboratory to the marketplace faster, a process called “technology transfer.” A $1.5 million grant from the Arizona Board of Regents will fund the project, called “A Roadmap to Fulfilling the Economic Potential of Technology Transfer in the Life Sciences and Biomedicine in Arizona.” Continue reading→

Bold. Forward. Unbound. in Arizona will reimagine the healthcare experience for patients and staff and expand clinical space on the Phoenix campus by nearly 60%Continue reading→

The Diane & Bruce Halle Foundation recently made a vital investment in Banner Health’s Graduate Medical Education program operated in partnership with the University of Arizona College of Medicine – Phoenix. This funding will increase the number of primary care residency positions available throughout Arizona, particularly in rural settings where the current and projected need for more primary care physicians is significant.Continue reading→

PHOENIX, Feb. 27, 2025 /PRNewswire/ — Brooks Rehabilitation, nationally acclaimed for its expertise in treating life-altering injuries, held a groundbreaking ceremony for its new 80,000-square-foot rehabilitation hospital on Mayo Clinic’s Phoenix campus.Continue reading→

The University of Arizona Health Sciences has appointed Dan Theodorescu, MD, PhD, as the director of the U of A Cancer Center, a National Cancer Institute-Designated Comprehensive Cancer Center. Theodorescu will begin his duties as the Nancy C. and Craig M. Berge Endowed Chair for the Director of the Cancer Center on March 1.
Continue reading→

Continue reading→

PathogenDx, a leader in next-generation microarray technology for better health and safety, announced the launch of its new rebranded D3 Array™ Combined, Bacterial and Fungal assays to replace Detectx–Combined,Detectx-Bacterial and Detectx-Fungal tests.Continue reading→

“With the February 18, 2025, decision by the U.S. District Court for the Eastern District of Texas in Smith, et al. v. U.S. Department of the Treasury, et al., 6:24-cv-00336 (E.D. Tex.), beneficial ownership information (BOI) reporting requirements under the Corporate
Transparency Act (CTA) are once again back in effect.”

According to FIN-2025-CTA1 (2/18/2025), for the vast majority of reporting companies, the new deadline to file an initial, updated, and/or corrected BOI report is now March 21, 2025. FinCEN will provide an update before then of any further modification of this deadline, recognizing that reporting companies may need additional time to comply with their BOI reporting obligations once this update is provided.

Companies that have not yet completed the FinCEN BOI process can access the full alert below.  Contact your legal advisers for further information. 

https://www.fincen.gov/sites/default/files/shared/FinCEN-BOI-Notice-Deadline-Extension-508FINAL.pdf